[Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
Over recent years, significant advances have been made in our knowledge of hepatitis C. Three observe special attention: 1) the possible nosocomial transmission of hepatitis C during invasive investigation; 2) the improved efficacy of bitherapy (interferon with ribavirine) over monotherapy in chronic hepatitis C; 3) the value of interferon therapy in acute hepatitis C before it turns to chronicity.
Delwaide
J
J
Service de Gastroentérologie, Université de Liège.
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000188:drug therapy* / Q000635:transmission*; D018450:Disease Progression; D006526:Hepatitis C / Q000188:drug therapy* / Q000635:transmission*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons